Three reports, one story: MiraOne to usher in new era of precision medicine through single blood test; grand launch in Mumbai

MUMBAI: MiraOne - a comprehensive blood test that promises to transform the way we study our body - was launched on Saturday in Mumbai at ImagiNXT conference attended by an impressive audience.

MiraOne, which has been conceived on the principle of “One test, One you” generates three reports to tell one story from a single draw of blood. It gives a complete picture - your blood markers, the DNA you inherited and how you respond to medicines.

Sample this:

A cardiologist prescribed folic acid for high homocysteine. Standard protocol. Except the patient's genes couldn't convert folic acid into anything useful. His body needed methylfolate instead. Without a genetic layer, he'd have stayed on a supplement that literally wouldn't work for his biology.

Most of the health tests will give results showing your homocysteine is elevated. That tells you there's a problem. It doesn't tell you why it's happening or what actually fixes it. You're basically staring at a warning light without understanding the engine.

This is the problem MiraOne actually aims to solve.

Launched by Nickhil Jakatdar and Abhinav Kejriwal, MiraOne sequences 120 million positions of your DNA, not just the 80K positions that most of the other tests sample. That's where the mutation hiding in your genes actually shows up. That's where the answer lies.

“Personalised medicine has been promised for two decades and delivered for almost no one. With Mira One, our team of doctors and geneticists are putting blood chemistry, whole exome sequencing, and pharmacogenomics into one consumer friendly report, read alongside your doctor. The future of healthcare isn’t more data. It’s the right data, intelligently integrated,” Nickhil Jakatdar told TOI. Dr. Nikhil Phadke was also present in the launch event.

The pharmacogenomics piece matters too. Some people metabolize medications slowly. Others burn through them. Your genes determine how your body actually responds to the drugs you're taking. Standard medicine ignores this. MiraOne doesn't.

The real innovation isn't the technology itself. It's combining three layers of information into one actionable diagnosis. Your blood tells you there's a problem. Your genes explain why. Your pharmacogenomics profile tells you which medication will actually work. Instead of trial and error, you get precision.

In a country where personalized medicine is still finding its footing, the timing matters. Healthcare in India is at an inflection point. People want answers beyond "take this because everyone else does."

MiraOne isn't selling a test. It's selling clarity. It's selling a path forward instead of guessing.

This is what precision medicine was supposed to be: One test, one you, one healthview.